Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Minerva Neurosciences (NERV) Other Non Operating Income (2016 - 2026)

Minerva Neurosciences filings provide 2 years of Other Non Operating Income readings, the most recent being -$4138.0 for Q4 2021.

  • On a quarterly basis, Other Non Operating Income rose 84.46% to -$4138.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$32846.0, a 51.11% increase, with the full-year FY2025 number at -$56555.0, down 2836.4% from a year prior.
  • Other Non Operating Income hit -$4138.0 in Q4 2021 for Minerva Neurosciences, up from -$4855.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of -$3661.0 in Q2 2020 to a low of -$27496.0 in Q3 2020.